Article View: be.science
Article #406Cancer - Press Review (June 16, 2012) – Revue de presse (16 juin 2012)
From: SMW
Date: Sat, 16 Jun 2012 19:05
Date: Sat, 16 Jun 2012 19:05
189 lines
9460 bytes
9460 bytes
Cancer – Press Review – Revue de Presse Every week on http://marclacroixcancerblog.blogspot.com Chaque semaine sur http://marclacroixcancerblog.blogspot.com Press Review (June 16, 2012) – Revue de presse (16 juin 2012) WHO agency: Diesel fumes cause cancer Diesel fumes cause cancer, the World Health Organization's cancer agency declared Tuesday, a ruling it said could make exhaust as important a public health threat as secondhand smoke. In USA Today http://www.usatoday.com/news/health/story/2012-06-13/cancer-diesel-exhaust-who/55579410/1 US cancer survivors to rise by a third by 2022-report The number of Americans living with cancer will increase by nearly a third to almost 18 million by 2022, according to a report released on Th ursday by the American Cancer Society and the National Cancer Institute. In Reuters http://www.reuters.com/article/2012/06/14/usa-cancer-projections-idUSL1E8HB7MX20120614 Cancer-fighting virus 'piggybacks' on blood cells A promising type of cancer treatment called viral therapy avoids detection by the body's immune system and reaches tumours by 'piggybacking' on blood cells. In Cancer Research UK http://info.cancerresearchuk.org/news/archive/cancernews/2012-06-13-Cancer-fighting-virus-piggybacks-on-blood-cells In one type of cancer, heavier men may live longer Extra pounds may not be good for your health in general, but heavy men appear more likely to survive a particular form of immune system cancer, a new study finds. By Amy Norton. In Reuters http://www.reuters.com/article/2012/06/12/us-cancer-heavier-men-idUSBRE85B19620120612 Young Cancer Survivors Often Face Long-Term Health Problems Many teens and young adults who survive cancer face other challenges later in life, such as unhealthy behaviors, chronic medical conditions and poor quality of life, according to a new report. In U.S. News & World Report http://health.usnews.com/health-news/news/articles/2012/06/11/young-cancer-survivors-often-face-long-term-health-problems Does More Dental Plaque Mean Higher Chances of Dying From Cancer? The gnarly plaque lurking on your gums and teeth may increase your chances of dying from cancer, new research suggests. By Denise Mann. In U.S. News & World Report http://health.usnews.com/health-news/news/articles/2012/06/12/does-more-dental-plaque-mean-higher-chances-of-dying-from-cancer Revealing Colon Cancer's Escape Route‎Taking periodic breaks from a Researchers have figured out why a popular therapy for treating colon cancer often eventually stops working: The tumors naturally carry genetic changes that allow some of their cells to evade the drug and keep growing. The good news is that physicians may be able to detect these changes in patients' blood and then halt the cancer with a different drug before it can grow again to a dangerous size. By Jocelyn Kaiser. In Science AAAS http://news.sciencemag.org/sciencenow/2012/06/revealing-colon-cancers-escape.html Identifying the origins of cervical cancer Researchers from Brigham and Women's Hospital uncover a population of cells that are targeted by the cancer-causing human papillomaviruses In EurekAlert http://www.eurekalert.org/pub_releases/2012-06/bawh-ito060812.php FDA Approves Pertuzumab (Perjeta) for HER2-Positive Breast Cancer Patients with HER2-positive breast cancer now have a new treatment option. Last week the US Food and Drug Administration (FDA) approved pertuzumab (Perjeta), a HER2-targeted antibody. The drug is approved in combination with trastuzumab (Herceptin) and docetaxel chemotherapy for women whose breast cancer overexpress the HER2 receptor and who have not received prior systemic treatment such as chemotherapy or trastuzumab monotherapy. By Anna Azvolinsky. In Cancer Network http://www.cancernetwork.com/breast-cancer/content/article/10165/2082951 New clinical trial design promises to accelerate cancer drug approvals Patients with early-stage breast cancer usually have to wait years to receive new cancer drugs but new guidance from the Food and Drug Administration (FDA) promises to reduce substantially the time and cost of getting new treatments to patients. The approach is based on a trial design being tested in the I-SPY 2 TRIAL, an innovative Phase II breast cancer trial By Erika Matich. In Medical Xpress http://medicalxpress.com/news/2012-06-clinical-trial-cancer-drug.html Les risques de cancer restent mal évalués‎‎ Le cancer est considéré comme "la maladie la plus grave" par 71 % des Français, devant le sida et les maladies cardio-vasculaires. C'est ce qui ressort du baromètre 2010 de l'Institut national de prévention et d'éducation pour la santé (Inpes) et de l'Institut national du cancer (INCa), publié jeudi 14 juin. L'enquête a été réalisée par téléphone auprès de 3 728 personnes, d'avril à août 2010. La précédente datait de 2005. Par Pascale Santi. Dans Le Monde http://www.lemonde.fr/vous/article/2012/06/14/les-risques-de-cancer-restent-mal-evalues_1718619_3238.html Diesel : les gaz d'échappement considérés comme cancérigènes En cause : leur implication dans des cas de cancers du poumon et de la vessie. Les gaz d'échappement des moteurs diesel sont « cancérigènes pour l'Homme » Dans Futura- Sciences http://www.futura-sciences.com/fr/news/t/medecine/d/diesel-les-gaz-dechappement-consideres-comme-cancerigenes_39381/ Cancer du sein: les Etats-Unis approuvent un traitement du laboratoire Roche L'Agence américaine des médicaments (FDA) a approuvé la molécule Perjeta, utilisée en combinaison avec un autre traitement contre le cancer, le Herceptin, et une chimiothérapie avec le docetaxel, pour traiter les patientes souffrant d'un cancer du sein HER2 positif n'ayant pas encore reçu de traitement. AFP http://www.google.com/hostednews/afp/article/ALeqM5gK5EEiBYe--eUQK6YQkfpTofacIg?docId=CNG.d5af4012c8e2d8c95005308729de1d22.511 Cancer de la vessie : pourquoi le BCG est l’une des meilleures armes ? Le BCG est utilisé depuis 35 ans pour éviter les récidives dans les cancers de la vessie car il a prouvé son efficacité. Mais comment l’optimiser ? La réponse vient d’être apportée : le traitement est d’autant plus efficace que le patient est au préalable immunisé contre la tuberculose… Par Janlou Chaput. Dans Futura-Sciences http://www.futura-sciences.com/fr/news/t/medecine/d/cancer-de-la-vessie-pourquoi-le-bcg-est-lune-des-meilleures-armes_39279/ Découverte d'une zone de cellules responsables des cancers de l'utérus "La plupart, sinon tous" les cancers utérins, provoqués en majorité par des papillomavirus humains, se développent dans des cellules spécifiques situées dans une seule région du col de l'utérus, selon des travaux publiés lundi aux Etats-Unis. Dans Le Nouvel Observateur http://tempsreel.nouvelobs.com/topnews/20120611.AFP9056/decouverte-d-une-zone-de-cellules-responsables-des-cancers-de-l-uterus.html Les scanners chez l'enfant augmentent le risque de cancer‎ L'irradiation délivrée dans l'enfance par 2 ou 3 scanners cérébraux triple le risque de cancer du cerveau. Et il faut 5 à 10 scanners du cerveau pour tripler le risque de leucémie. Dans Le Nouvel Observateur http://pourquoi-docteur.nouvelobs.com/Les-scanners-chez-l-enfant-augmentent-le-risque-de-cancer-854.html Cancer Blog – Marc Lacroix – Le Blogue du Cancer http://marclacroixcancerblog.blogspot.com Marc Lacroix-Corman – InTextoResearch – Baelen (06/2012)
Technical Details
Message-ID:
<6e3c5e86-dd4a-421e-b708-cca8a28ae78f@l5g2000vbo.googlegroups.com>Path:
arc1-ca.pugleaf.net!l9ni58307pbj.0!nntp.google.com!news1.google.com!postnews.google.com!l5g2000vbo.googlegroups.com!not-for-mailShow Full Headers
Complete Article Headers
X-Google-Thread: f5500,5f60a1e2c0e834ec,start
X-Google-NewGroupId: yes
X-Google-Attributes: gida254ea4a8d,domainid0,public,usenet
X-Google-Language: ENGLISH,UTF8
Received: by 10.68.234.38 with SMTP id ub6mr10452622pbc.2.1339873545375;
Sat, 16 Jun 2012 12:05:45 -0700 (PDT)
Path: arc1-ca.pugleaf.net!l9ni58307pbj.0!nntp.google.com!news1.google.com!postnews.google.com!l5g2000vbo.googlegroups.com!not-for-mail
From: SMW <scimedweb@mail.com>
Newsgroups: be.science
Subject: Cancer - Press Review (June 16, 2012) – Revue de presse (16 juin 2012)
Date: Sat, 16 Jun 2012 12:05:44 -0700 (PDT)
Organization: http://groups.google.com
Lines: 189
Message-ID: <6e3c5e86-dd4a-421e-b708-cca8a28ae78f@l5g2000vbo.googlegroups.com>
NNTP-Posting-Host: 81.247.94.191
Mime-Version: 1.0
X-Trace: posting.google.com 1339873545 19062 127.0.0.1 (16 Jun 2012 19:05:45 GMT)
X-Complaints-To: groups-abuse@google.com
NNTP-Posting-Date: Sat, 16 Jun 2012 19:05:45 +0000 (UTC)
Complaints-To: groups-abuse@google.com
Injection-Info: l5g2000vbo.googlegroups.com; posting-host=81.247.94.191; posting-account=jR3pwAkAAABfF7uqn-zMzWqez-yhPWKE
User-Agent: G2/1.0
X-HTTP-UserAgent: Opera/9.80 (Windows NT 5.1; U; fr) Presto/2.10.289 Version/12.00,gzip(gfe)
Content-Type: text/plain; charset=UTF-8
Content-Transfer-Encoding: quoted-printable